Daniel J. Vis

Citée par

	Toutes	Depuis 2019
Citations	7324	5111
indice h	26	24
indice i10	35	33

1000

500

250

750

2008200920102011201220132014201520162017201820192020202120222023202454 68 85 91 156 181 191 173 250 383 512 559 700 934 972 992 943

Accès public

Tout afficher

25 articles

1 article

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

Lodewyk WesselsProfessor of Computational Cancer BiologyAdresse e-mail validée de nki.nl
age smildeprofessor of biosystems data analysisAdresse e-mail validée de uva.nl
Johan WesterhuisUniversity of AmsterdamAdresse e-mail validée de uva.nl
huub hoefslootassociate professor in systems data analysis, university of AmsterdamAdresse e-mail validée de uva.nl
John van DuynhovenUnilever R&D Wageningen University Twente University Nijmegen UniversityAdresse e-mail validée de unilever.com
Jeremy LewinPeter MacCallum Cancer CentreAdresse e-mail validée de petermac.org
Lillian SiuPrincess Margaret Cancer CentreAdresse e-mail validée de uhn.ca
Magali MichautDanStem, Copenhagen University, DenmarkAdresse e-mail validée de sund.ku.dk
Robyn Lynne WardUniversity of QueenslandAdresse e-mail validée de unsw.edu.au
Renger JellemaSenior Scientist, DSMAdresse e-mail validée de dsm-firmenich.com
Harmen J. BussemakerColumbia UniversityAdresse e-mail validée de columbia.edu
Francesco IorioHuman TechnopoleAdresse e-mail validée de fht.org
Gertien Smitsleraar scheikunde, Montessori Lyceum Terra NovaAdresse e-mail validée de msa.nl
Stanley BrulProfessor of Molecular Biology and Microbial Food SafetyAdresse e-mail validée de uva.nl
Oscar krijgsmanPrinciple Bioinformatician, Neogene TherapeuticsAdresse e-mail validée de neogene.com
David HausslerScientific Director, UC Santa Cruz Genomics Institute, University of California, Santa CruzAdresse e-mail validée de soe.ucsc.edu
Suzan WopereisPrincipal scientist, TNOAdresse e-mail validée de tno.nl
Ben van OmmenPrincipal Scientist, TNOAdresse e-mail validée de tno.nl
Petra M NederlofNetherlands Cancer Institute NKIAdresse e-mail validée de nki.nl
Mateusz KadukKarolinska Institutet, Department of Microbiology, Tumor and Cell BiologyAdresse e-mail validée de ki.se

Suivre

Daniel J. Vis

Netherlands Cancer Institute, Amsterdam, The Netherlands

Adresse e-mail validée de nki.nl

d.vis@nki.nl


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
A landscape of pharmacogenomic interactions in cancer F Iorio, TA Knijnenburg, DJ Vis, GR Bignell, MP Menden, M Schubert, ... Cell 166 (3), 740-754, 2016	1883	2016
Assessment of PLSDA cross validation JA Westerhuis, HCJ Hoefsloot, S Smit, DJ Vis, AK Smilde, EJJ van Velzen, ... Metabolomics 4, 81-89, 2008	1578	2008
Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients SN Ooft, F Weeber, KK Dijkstra, CM McLean, S Kaing, E van Werkhoven, ... Science translational medicine 11 (513), eaay2574, 2019	600	2019
Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial N van Dijk, A Gil-Jimenez, K Silina, K Hendricksen, LA Smit, JM de Feijter, ... Nature medicine 26 (12), 1839-1844, 2020	334	2020
Selective loss of PARG restores PARylation and counteracts PARP inhibitor-mediated synthetic lethality E Gogola, AA Duarte, JR de Ruiter, WW Wiegant, JA Schmid, R de Bruijn, ... Cancer cell 33 (6), 1078-1093. e12, 2018	292	2018
Effective drug combinations in breast, colon and pancreatic cancer cells P Jaaks, EA Coker, DJ Vis, O Edwards, EF Carpenter, SM Leto, L Dwane, ... Nature 603 (7899), 166-173, 2022	271	2022
Subunit composition of VRAC channels determines substrate specificity and cellular resistance to P t‐based anti‐cancer drugs R Planells‐Cases, D Lutter, C Guyader, NM Gerhards, F Ullrich, DA Elger, ... The EMBO journal 34 (24), 2993-3008, 2015	250	2015
T-profiler: scoring the activity of predefined groups of genes using gene expression data A Boorsma, BC Foat, D Vis, F Klis, HJ Bussemaker Nucleic acids research 33 (suppl_2), W592-W595, 2005	243	2005
Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer M Michaut, SF Chin, I Majewski, TM Severson, T Bismeijer, L De Koning, ... Scientific reports 6 (1), 1-13, 2016	205	2016
Genome-wide analysis of yeast stress survival and tolerance acquisition to analyze the central trade-off between growth rate and cellular robustness A Zakrzewska, G Van Eikenhorst, JEC Burggraaff, DJ Vis, H Hoefsloot, ... Molecular biology of the cell 22 (22), 4435-4446, 2011	167	2011
Statistical validation of megavariate effects in ASCA DJ Vis, JA Westerhuis, AK Smilde, J van der Greef BMC bioinformatics 8, 1-8, 2007	162	2007
Intra‐and inter‐tumor heterogeneity in a vemurafenib‐resistant melanoma patient and derived xenografts K Kemper, O Krijgsman, P Cornelissen‐Steijger, A Shahrabi, F Weeber, ... EMBO molecular medicine 7 (9), 1104-1118, 2015	157	2015
Dynamic metabolomic data analysis: a tutorial review AK Smilde, JA Westerhuis, HCJ Hoefsloot, S Bijlsma, CM Rubingh, DJ Vis, ... Metabolomics 6, 3-17, 2010	121	2010
Phenotyping tea consumers by nutrikinetic analysis of polyphenolic end-metabolites EJJ van Velzen, JA Westerhuis, JPM van Duynhoven, FA van Dorsten, ... Journal of proteome research 8 (7), 3317-3330, 2009	114	2009
MAP3K1 and MAP2K4 mutations are associated with sensitivity to MEK inhibitors in multiple cancer models Z Xue, DJ Vis, A Bruna, T Sustic, S van Wageningen, AS Batra, ... Cell research 28 (7), 719-729, 2018	110	2018
Facilitating a culture of responsible and effective sharing of cancer genome data LL Siu, M Lawler, D Haussler, BM Knoppers, J Lewin, DJ Vis, RG Liao, ... Nature medicine 22 (5), 464-471, 2016	104	2016
TANDEM: a two-stage approach to maximize interpretability of drug response models based on multiple molecular data types N Aben, DJ Vis, M Michaut, LF Wessels Bioinformatics 32 (17), i413-i420, 2016	94	2016
Multilevel models Improve precision and Speed of IC₅₀ Estimates DJ Vis, L Bombardelli, H Lightfoot, F Iorio, MJ Garnett, LFA Wessels Pharmacogenomics 17 (7), 691-700, 2016	84	2016
Identification of a druggable pathway controlling glioblastoma invasiveness N Pencheva, MC de Gooijer, DJ Vis, LFA Wessels, T Würdinger, ... Cell reports 20 (1), 48-60, 2017	77	2017
Evaluation of the HER/PI3K/AKT family signaling network as a predictive biomarker of pathologic complete response for patients with breast cancer treated with neratinib in the … JD Wulfkuhle, C Yau, DM Wolf, DJ Vis, RI Gallagher, L Brown-Swigart, ... JCO precision oncology 2, 1-20, 2018	53	2018

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs